COLOTECT® – Naleya Genomik Indonesia

Early Detection of Colorectal Cancer Saves Lives

90% of colorectal cancer cases can be cured if detected early!

A condition arising from uncontrolled cell growth in the large intestine and rectum

The growth of this cancer is relatively slow,
requiring 5-15 years to develop

Based on the latest data from 2022, colorectal cancer ranks fourth among cancer cases in Indonesia, comprising 8.7% of all cancer cases

It’s a simple test that checks for colorectal cancer marker genes, helping those at risk find out their status early on

Experience a comfortable and private sample collection process

> 90% sensitivity for colorectal cancer and > 50% for advanced precancerous lesions

Options for a non-invasive, painless test using fecal samples, with no need for special preparations

Benefit from multi-biomarker genes SDC2, PPP2R5C, ADHFE1 in sDNA, enhancing the accuracy of early colorectal cancer detection

Consider COLOTECT® as your proactive step towards early detection and a healthier future.

It’s tailored for those who want to stay ahead of potential risks.

Consuming alcoholic beverages:
Moderate or excessive, it's a factor

A smoker:
Kick the habit, and stay vigilant

Leading an unhealthy lifestyle:
Your habits impact your health

Over 40 years old:
Even if you don't have symptoms

With a family history of cancer:
Genetics can play a role

History of polyps or inflammatory bowel disease:
Past experiences matter

Dealing with obesity:
Extra weight can be a risk factor